Custom immune cells unleashed against multiple cancers in pioneering trial
NCT ID NCT05973487
Summary
This early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their specific cancer, and then infuse them back. The trial is enrolling adults with various cancers, including those linked to HPV, to see if single or combination cell therapies are safe and show early signs of fighting the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Hospitals Network
Pittsburgh, Pennsylvania, 15224, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
HonorHealth Research and Innovation Institute
Scottsdale, Arizona, 85258, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Memorial Healthcare System
Hollywood, Florida, 33021, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
Oncology Hematology Care
Cincinnati, Ohio, 45242, United States
-
Orlando Health
Orlando, Florida, 32806, United States
-
Providence Cancer Institute Franz Clinic
Portland, Oregon, 97213, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
The Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
University of California San Diego
San Diego, California, 92037, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Miami, Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
University of Minnesota Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States
-
University of South Florida
Tampa, Florida, 33606, United States
-
Yale Cancer Center
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.